Source:http://linkedlifedata.com/resource/pubmed/id/12124464
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 8
|
pubmed:dateCreated |
2002-7-18
|
pubmed:abstractText |
Glycoprotein B (gB) of human cytomegalovirus (HCMV) is the dominating protein in the envelope of this virus and gives rise to virus-neutralizing antibodies in most infected individuals. We have previously isolated a neutralizing human antibody specific for antigenic domain 2 (AD-2) on gB, a poorly immunogenic epitope, which nevertheless is capable of eliciting potent neutralizing antibodies. In order to define parameters important for the neutralization of HCMV via gB, we have investigated the virus-neutralizing capacity and the kinetics of the interaction with AD-2 of the monomeric and dimeric forms of a single chain variable fragment (scFv) corresponding to this antibody. We demonstrate here that neutralization of HCMV via AD-2 on gB can be mediated by dimeric scFv, while monomeric fragments cannot mediate neutralization of the virus, despite a slow dissociation from the intact glycoprotein. This finding is discussed in the context of possible mechanisms for antibody-mediated virus neutralization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Envelope Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/glycoprotein B, Simplexvirus
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1317
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2001-5
|
pubmed:dateRevised |
2008-8-26
|
pubmed:meshHeading |
pubmed-meshheading:12124464-Amino Acid Sequence,
pubmed-meshheading:12124464-Antibodies, Viral,
pubmed-meshheading:12124464-Antigens, Viral,
pubmed-meshheading:12124464-Cell Line,
pubmed-meshheading:12124464-Cytomegalovirus,
pubmed-meshheading:12124464-Dimerization,
pubmed-meshheading:12124464-Fluorescent Antibody Technique,
pubmed-meshheading:12124464-Humans,
pubmed-meshheading:12124464-Immunoglobulin Fragments,
pubmed-meshheading:12124464-Kinetics,
pubmed-meshheading:12124464-Molecular Sequence Data,
pubmed-meshheading:12124464-Neutralization Tests,
pubmed-meshheading:12124464-Peptides,
pubmed-meshheading:12124464-Viral Envelope Proteins
|
pubmed:year |
2002
|
pubmed:articleTitle |
A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.
|
pubmed:affiliation |
Department of Immunotechnology, Lund University, PO Box 7031, S-220 07 Lund, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|